Compared to existing literature, our work offers two key contributions: (1) it underscores the importance of DNMT1 as a driver of breast cancer brain metastases, and (2) it identifies RASSF1A as a direct downstream effector of DNMT1-mediated DNA methylation [73, 74]. This evidence concerns the gene DNMT1 and breast carcinoma.